Bryan Supran
Directeur/Bestuurslid bij ANACOR PHARMACEUTICALS INC
Vermogen: 206 959 $ op 31-05-2024
Profiel
Bryan Supran is currently the Director at Anacor Pharmaceuticals LLC, the Non-Executive Director at Haleon Plc, and the Senior Vice President & Deputy General Counsel at Pfizer Inc. He previously worked as a Director at Medivation LLC (California), Viatris, Inc., and Array BioPharma, Inc. He also served as a Director at Haleon UK Holdings (No.2) Ltd.
from 2019 to 2022.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HALEON PLC
0.00% | 31-12-2023 | 50 000 ( 0.00% ) | 206 959 $ | 31-05-2024 |
Actieve functies van Bryan Supran
| Bedrijven | Functie | Begin |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Directeur/Bestuurslid | 24-06-2016 |
| HALEON PLC | Directeur/Bestuurslid | 18-07-2022 |
| PFIZER, INC. | Algemeen Adviseur | 01-04-2016 |
Eerdere bekende functies van Bryan Supran
| Bedrijven | Functie | Einde |
|---|---|---|
Haleon UK Holdings (No.2) Ltd.
 Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Directeur/Bestuurslid | 18-07-2022 |
| VIATRIS INC. | Directeur/Bestuurslid | 16-11-2020 |
| ARRAY TECHNOLOGIES, INC. | Directeur/Bestuurslid | - |
| MEDIVATION INC | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VIATRIS INC. | Health Technology |
| HALEON PLC | Distribution Services |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Finance |
